Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Leren

Showing results (71-80 of 302) with videos related to

Pageof 31
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 29, 2004
[Gitelman's syndrome--a differential diagnosis in hypokalemia]Anders Hovland, Eyvind Bjørbaek, Trond P Leren
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2004
[A family-based strategy for diagnosing familial hypercholesterolemia]Trond P Leren, Turid Manshaus, Leiv Ose
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 24, 1998
[Diagnosis and treatment of severe hyperlipidemia]S Tonstad, T P Leren, L Ose
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 12, 2001
[Genetic screening and treatment in familial hypercholesterolemia]T P Leren, S Tonstad, L Ose
American Heart Journal|November 1, 1983
The Oslo study: CHD risk factors, socioeconomic influences, and interventionP Leren, A Helgeland, I Hjermann, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Socio-economic status as a coronary risk factor: the Oslo studyI Holme, A Helgeland, I Hjermann, et al.
The American Journal of Medicine|January 1, 1978
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo studyA Helgeland, I Hjermann, I Holme, et al.
Clinical Genetics|May 1, 1985
Low density lipoprotein receptor activity in cultured skin fibroblasts from octa- and nonagenariansT P Leren, K Maartmann-Moe, K Berg
The Biochemical Journal|October 23, 2013
PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Trond P Leren
Human Molecular Genetics|October 11, 2019
Bone morphogenetic protein 1 cleaves the linker region between ligand-binding repeats 4 and 5 of the LDL receptor and makes the LDL receptor non-functionalThea Bismo Strøm, Katrine Bjune, Trond P Leren
Pageof 31

Showing results (71-80 of 302) with videos related to

Sort By:
Pageof 31
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 29, 2004
[Gitelman's syndrome--a differential diagnosis in hypokalemia]Anders Hovland, Eyvind Bjørbaek, Trond P Leren
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2004
[A family-based strategy for diagnosing familial hypercholesterolemia]Trond P Leren, Turid Manshaus, Leiv Ose
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 24, 1998
[Diagnosis and treatment of severe hyperlipidemia]S Tonstad, T P Leren, L Ose
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 12, 2001
[Genetic screening and treatment in familial hypercholesterolemia]T P Leren, S Tonstad, L Ose
American Heart Journal|November 1, 1983
The Oslo study: CHD risk factors, socioeconomic influences, and interventionP Leren, A Helgeland, I Hjermann, et al.
Acta Medica Scandinavica. Supplementum|January 1, 1982
Socio-economic status as a coronary risk factor: the Oslo studyI Holme, A Helgeland, I Hjermann, et al.
The American Journal of Medicine|January 1, 1978
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo studyA Helgeland, I Hjermann, I Holme, et al.
Clinical Genetics|May 1, 1985
Low density lipoprotein receptor activity in cultured skin fibroblasts from octa- and nonagenariansT P Leren, K Maartmann-Moe, K Berg
The Biochemical Journal|October 23, 2013
PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulumThea Bismo Strøm, Kristian Tveten, Trond P Leren
Human Molecular Genetics|October 11, 2019
Bone morphogenetic protein 1 cleaves the linker region between ligand-binding repeats 4 and 5 of the LDL receptor and makes the LDL receptor non-functionalThea Bismo Strøm, Katrine Bjune, Trond P Leren
Pageof 31